Bristol Myers Squibb (BMY) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket
 


Bristol myers Squibb Company  (NYSE: BMY)

Bristol Myers Squibb Profitability Comparisons

Select each Category to receive further Information




BMY Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q1 MRQ) 70.22 % 70.91 % 65.43 % 46.08 %
Gross Margin (Q1 TTM) 70.46 % 71.7 % 65.99 % 46.3 %
Gross Profit Margin 5 Yr. Avg. 75 % 67.81 % 65.55 % 48.95 %
EBITDA Margin (Q1 MRQ) 33.37 % 21.45 % 18.99 % 20.49 %
EBITDA Margin (Q1 TTM) 27.21 % 25.15 % 21.01 % 20.13 %
EBITDA Margin 5 Yr. Avg. 30.02 % 47.09 % 31.38 % 23.41 %
Operating Margin (Q1 MRQ) 28.47 % 17.27 % 16.58 % 16.05 %
Operating Margin (Q1 TTM) 20.55 % 20.33 % 17.81 % 16.34 %
Operating Margin 5 Yr. Avg. 11.06 % 15.37 % 14.33 % 19.26 %
Pre-Tax Profit Margin (Q1 MRQ) 28.2 % 13.66 % 10.94 % 13.96 %
Pre-Tax Profit Margin (Q1 TTM) 19.79 % 16.7 % 12.79 % 13.09 %
Pre-Tax Profit Margin 5 Yr. Avg. 10.99 % 12.98 % 10.37 % 13.52 %
Net Margin (Q1 MRQ) 23.31 % 10.09 % 8.15 % 11.42 %
Net Margin (Q1 TTM) 15 % 13.13 % 9.94 % 10.76 %
Net Margin 5 Yr. Avg. 8.58 % 5.79 % 6.08 % 10.8 %



Business Segment Profit Margin
 
Net product sales
  Explore Net product sales Segment  -
Alliance revenues
  Explore Alliance revenues Segment  -
Other revenues
  Explore Other revenues Segment  -
United States
  Explore United States Segment  -
International
  Explore International Segment  -
Other
  Explore Other Segment  -
Growth Portfolio
  Explore Growth Portfolio Segment  -
Opdivo
  Explore Opdivo Segment  -
Orencia
  Explore Orencia Segment  -
Yervoy
  Explore Yervoy Segment  -
Reblozyl
  Explore Reblozyl Segment  -
Opdualag
  Explore Opdualag Segment  -
Zeposia
  Explore Zeposia Segment  -
Breyanzi
  Explore Breyanzi Segment  -
Camzyos
  Explore Camzyos Segment  -
Sotyktu
  Explore Sotyktu Segment  -
Krazati
  Explore Krazati Segment  -
Other Growth products
  Explore Other Growth products Segment  -
Legacy Portfolio
  Explore Legacy Portfolio Segment  -
Eliquis
  Explore Eliquis Segment  -
Revlimid
  Explore Revlimid Segment  -
Pomalyst Imnovid
  Explore Pomalyst Imnovid Segment  -
Sprycel
  Explore Sprycel Segment  -
Abraxane
  Explore Abraxane Segment  -
Other Legacy products
  Explore Other Legacy products Segment  -
Gross product sales
  Explore Gross product sales Segment  -
Opdivo Qvantig
  Explore Opdivo Qvantig Segment  -
Cobenfy
  Explore Cobenfy Segment  -
Other revenue
  Explore Other revenue Segment  -
 

Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q1 MRQ) 6.59 % -0.01 % 0.21 % 1.39 %
Free Cash Flow Margin (Q1 TTM) 24.56 % 17.24 % 13.85 % 9.11 %
Free Cash Flow Margin 5 Yr. Avg. - 19.28 % 14.86 % 15.58 %
Net Cash Flow Margin (Q1 MRQ) -5.53 % 0.02 % -0.02 % 0.13 %
Net Cash Flow Margin (Q1 TTM) -2.66 % -0.66 % 0.13 % 1.85 %
Net Cash Flow Margin 5 Yr. Avg. - 4.38 % 3.16 % 6.44 %
Effective Tax Rate (Q1 MRQ) 17.31 % 25.98 % 25.39 % 18.83 %
Effective Tax Rate (Q1 TTM) 24.22 % 21.21 % 22.93 % 19.44 %
Effective Tax Rate 5 Yr. Avg. - 15.08 % 20.51 % 19.76 %
Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.